Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 EUR | +0.47% | -4.93% | -57.34% |
May. 03 | Crossject: praised for extended agreement on Zepizure | CF |
May. 02 | Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe | CI |
Sales 2023 | 12.83M 13.81M | Sales 2024 * | 3.7M 3.98M | Capitalization | 80.61M 86.82M |
---|---|---|---|---|---|
Net income 2023 | -8M -8.62M | Net income 2024 * | -15M -16.15M | EV / Sales 2023 | 14.7 x |
Net Debt 2023 * | 25.8M 27.79M | Net Debt 2024 * | 27.8M 29.94M | EV / Sales 2024 * | 29.3 x |
P/E ratio 2023 * |
-3.72
x | P/E ratio 2024 * |
-5.3
x | Employees | 110 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 61.48% |
1 day | +0.47% | ||
1 week | -4.93% | ||
Current month | +3.41% | ||
1 month | -2.08% | ||
3 months | -47.00% | ||
6 months | -51.38% | ||
Current year | -57.34% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 01-08-07 | |
Olivier Giré
PRN | Corporate Officer/Principal | - | 15-12-31 |
Corporate Officer/Principal | - | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Teper
BRD | Director/Board Member | 64 | 23-06-06 |
Eric Nemeth
BRD | Director/Board Member | 65 | - |
Philippe Monnot
CHM | Chairman | 65 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.12 | +0.47% | 53,219 |
24-05-09 | 2.11 | -2.31% | 51,161 |
24-05-08 | 2.16 | -0.92% | 22,097 |
24-05-07 | 2.18 | +2.11% | 15,344 |
24-05-06 | 2.135 | -4.26% | 110,144 |
Real-time Euronext Paris, May 10, 2024 at 11:16 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALCJ Stock